Groundbreaking genomic test could spare millions of breast cancer patients chemotherapy
Trial suggests patients with a low test score could be treated with hormone therapy alone with near-identical outcomes
https://www.theguardian.com/society/2026/may/29/breast-cancer-chemotherapy-genomic-test-case-study">‘Like Christmas’: woman’s relief after test finds she can skip chemotherapy
Millions of women with breast cancer could be spared chemotherapy with a groundbreaking genomic test, according to the results of a trial that could transform healthcare guidelines worldwide.
https://www.theguardian.com/science/2026/jan/18/simple-blood-test-can-predict-which-breast-cancer-treatment-will-work-best-study-finds">Treatment for breast cancer, the world’s most prevalent form of the disease, involves surgery to remove tumours.
Chemotherapy is then usually recommended when doctors believe there is a risk the disease will return.
https://www.theguardian.com/society/2026/may/29/groundbreaking-genomic-test-spare-breast-cancer-patients-chemotherapy-hormone-therapy">Continue reading...Breast Cancer Test Breakthrough
- Breast cancer patient spared chemotherapy through groundbreaking trial says it felt ‘like Christmas’ ITV —
- Doctors hail cancer injection that can destroy entire tumors The Independent —
- ‘ADC therapy effective in cancer treatment’ Times Of India —
- Cancer jab can eradicate entire tumours in patients, trial shows Irish Times —
- Cancer jabs destroy whole tumours in treatment-resistant cases, trial shows The Standard —